封面
市场调查报告书
商品编码
1779737

全球细胞库外包市场

Cell Banking Outsourcing

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 366 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年,全球细胞银行外包市场规模将达到 340 亿美元

全球细胞库外包市场规模预计在2024年达到139亿美元,预计2024年至2030年期间的复合年增长率为16.1%,到2030年将达到340亿美元。主细胞库是本报告分析的细分市场之一,预计其复合年增长率为18.5%,到分析期结束时规模将达到197亿美元。工作细胞库细分市场在分析期间的复合年增长率预计为14.8%。

美国市场规模估计为 38 亿美元,中国市场预计复合年增长率为 21.7%

预计2024年,美国手机银行外包市场规模将达38亿美元。作为世界第二大经济体,中国市场规模预计到2030年将达到76亿美元,在2024-2030年的分析期间内,复合年增长率将达到21.7%。其他值得关注的区域市场包括日本和加拿大,预计在分析期间内,这两个市场的复合年增长率分别为11.6%和14.6%。在欧洲,预计德国市场的复合年增长率约为12.9%。

全球细胞库外包市场-主要趋势与驱动因素摘要

为什么细胞银行外包的需求不断增加?

随着细胞疗法、再生医学和生物製药研究的日益普及,细胞库外包的需求也日益增长。随着製药和生物技术公司专注于细胞和基因疗法、个人化医疗和疫苗生产的开发,对高品质、保存完好的细胞株的需求也显着增加。外包细胞库服务使研究机构和药物开发公司能够保存、扩展和管理细胞株,而无需承担维护昂贵内部基础设施的负担。

干细胞疗法、单株抗体和生技药品临床试验的兴起进一步推动了细胞库外包的需求。细胞产品开发的复杂性要求严格的品管、遵守良好生产规范 (细胞株,这进一步增加了对可靠、专业的细胞库服务的需求。

科技进步如何改善细胞库外包?

冷冻保存、自动化生物处理和品质保证技术的创新正在彻底改变细胞库的外包流程,提高长期细胞储存的效率和可靠性。其中最重要的进步之一是先进冷冻保护剂和可控冷冻速率的开发,这提高了储存细胞的活力和稳定性。这些创新降低了遗传漂变和细胞劣化的风险,确保了生物样本能够长期用于研究和治疗应用。

另一项重大突破是将人工智慧和自动化技术融入细胞库业务。人工智慧预测分析和机器人处理系统正在提高流程一致性,减少人为错误,并优化储存条件。此外,区块链技术正在被探索用于安全的资料管理和可追溯性,确保细胞库记录的完全透明和合规性。采用云端基础的样本追踪和数位库存管理系统进一步提高了业务效率,并允许客户即时远端监控和管理其储存的细胞株。

哪些市场趋势推动了细胞银行外包产业的发展?

对再生医学和细胞疗法开发的日益关注是影响细胞库外包市场的最具影响力的趋势之一。随着干细胞研究在神经退化性疾病、心血管疾病和罕见遗传疾病治疗的应用日益广泛,对高品质干细胞库服务的需求也日益增长。生物製药公司也越来越依赖外包细胞库来大规模生产生技药品,包括单株抗体和重组蛋白。

影响市场成长的另一个关键趋势是监管部门对良好生产规范 (GMP) 和标准化细胞储存通讯协定的重视。随着全球监管机构收紧细胞疗法生产和储存的指导方针,外包供应商正在投资更高的生物安全水平、符合 GMP 标准的设施和先进的监控系统,以满足行业标准。此外,生物技术研究领域的国际合作日益增多,推动了对集中式细胞库服务的需求,这使得公司能够跨多个地区获取高品质的细胞株。随着基于细胞的研究和治疗方法的快速扩展,外包细胞库已成为许多生命科学公司的策略性必需。

影响细胞银行外包市场未来发展的关键成长动力有哪些?

细胞库外包市场的成长受到多种因素的推动,包括对细胞疗法的需求不断增长、生物保存技术的进步以及对生物製药研究的投资不断增加。主要成长要素之一是细胞和基因疗法临床试验的扩展,这些试验需要安全且控制良好的细胞株来进行开发和获得监管部门的核准。随着製药公司和研究机构加快在再生医学领域的布局,对可靠的细胞库合作伙伴的需求也日益增长。

影响市场的另一个关键驱动因素是个人化医疗和精准治疗的日益普及。随着细胞疗法越来越针对特定患者,对客製化细胞库解决方案的需求也日益增长,包括自体和异体细胞储存服务。此外,生物製药公司与受託製造厂商(CDMO) 之间日益增多的合作,使得更具可扩展性和成本效益的外包解决方案成为可能。随着生命科学产业的持续创新,细胞库外包预计将在促进治疗方法突破、确保样本长期保存以及支持下一代生物製药的开发方面发挥关键作用。

部分

类型(主细胞库、工作细胞库、病毒细胞库);细胞类型(干细胞、非干细胞);阶段(库保存阶段、库表征和测试阶段、库准备阶段)

受访公司范例

  • ATCC(American Type Culture Collection)
  • BioOutsource Ltd.
  • BioReliance Corporation
  • BSL Bioservice
  • CellBank Australia
  • Charles River Laboratories, Inc.
  • Clean Biologics
  • Cordlife Group Limited
  • Covance Inc.
  • Cryo-Cell International Inc.
  • Cryoviva India
  • Eurofins Scientific
  • GBI
  • LifeCell International Pvt. Ltd
  • Lonza Group Ltd.
  • Merck KGaA
  • Paragon Bioservices, Inc.
  • Reliance Life Sciences
  • Sartorius AG
  • SGS Life Sciences

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范,而是建立了一个从世界各地专家收集的内容库,包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况(成品和原始OEM)预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手,包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP29864

Global Cell Banking Outsourcing Market to Reach US$34.0 Billion by 2030

The global market for Cell Banking Outsourcing estimated at US$13.9 Billion in the year 2024, is expected to reach US$34.0 Billion by 2030, growing at a CAGR of 16.1% over the analysis period 2024-2030. Master Cell Banking, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$19.7 Billion by the end of the analysis period. Growth in the Working Cell Banking segment is estimated at 14.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.8 Billion While China is Forecast to Grow at 21.7% CAGR

The Cell Banking Outsourcing market in the U.S. is estimated at US$3.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2030 trailing a CAGR of 21.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.6% and 14.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.9% CAGR.

Global Cell Banking Outsourcing Market - Key Trends & Drivers Summarized

Why Is the Demand for Cell Banking Outsourcing Increasing?

The demand for cell banking outsourcing is increasing due to the rising adoption of cell-based therapies, regenerative medicine, and biopharmaceutical research. As pharmaceutical and biotechnology companies focus on the development of cell and gene therapies, personalized medicine, and vaccine production, the need for high-quality, well-preserved cell lines has grown significantly. Outsourcing cell banking services allows research institutions and drug developers to store, expand, and manage their cell lines without the burden of maintaining costly in-house infrastructure.

The increasing number of clinical trials for stem cell therapies, monoclonal antibodies, and biologics has further fueled the demand for cell banking outsourcing. The complexity of cell-based product development requires stringent quality control, compliance with Good Manufacturing Practices (GMP), and secure long-term storage, making outsourcing an attractive option for companies looking to optimize costs and ensure regulatory compliance. Additionally, as personalized medicine continues to evolve, there is a growing emphasis on ensuring the safety, traceability, and viability of cell lines, further driving the need for reliable and specialized cell banking services.

How Are Technological Advancements Improving Cell Banking Outsourcing?

Innovations in cryopreservation, automated bioprocessing, and quality assurance techniques are revolutionizing cell banking outsourcing, improving the efficiency and reliability of long-term cell storage. One of the most significant advancements is the development of advanced cryoprotectants and controlled-rate freezing technologies, which enhance the viability and stability of stored cells. These innovations reduce the risks of genetic drift and cell degradation, ensuring the long-term usability of biological samples for research and therapeutic applications.

Another major breakthrough is the integration of artificial intelligence and automation in cell banking operations. AI-driven predictive analytics and robotic handling systems are improving process consistency, reducing human error, and optimizing storage conditions. Additionally, blockchain technology is being explored for secure data management and traceability, ensuring full transparency and compliance in cell banking records. The adoption of cloud-based sample tracking and digital inventory management systems is further enhancing operational efficiency, allowing clients to remotely monitor and manage their stored cell lines in real time.

Which Market Trends Are Driving Growth in the Cell Banking Outsourcing Industry?

The increasing focus on regenerative medicine and cell therapy development is one of the most influential trends shaping the cell banking outsourcing market. With stem cell research gaining momentum for treating neurodegenerative disorders, cardiovascular diseases, and rare genetic conditions, demand for high-quality stem cell banking services is growing. Biopharmaceutical companies are also expanding their reliance on outsourced cell banking for large-scale production of biologics, including monoclonal antibodies and recombinant proteins.

Another key trend influencing market growth is the regulatory emphasis on Good Manufacturing Practices and standardized cell preservation protocols. As global regulatory agencies tighten guidelines on cell therapy manufacturing and storage, outsourcing providers are investing in higher biosafety levels, GMP-compliant facilities, and advanced monitoring systems to meet industry standards. Additionally, the rise of international collaborations in biotech research is driving demand for centralized cell banking services, allowing companies to access high-quality cell lines across multiple regions. With the rapid expansion of cell-based research and therapeutics, outsourcing cell banking has become a strategic necessity for many life sciences companies.

What Are the Key Growth Drivers Shaping the Future of the Cell Banking Outsourcing Market?

The growth in the cell banking outsourcing market is driven by several factors, including increasing demand for cell-based therapies, advancements in biopreservation technologies, and rising investments in biopharmaceutical research. One of the primary growth drivers is the expansion of clinical trials for cell and gene therapies, which require secure and well-maintained cell lines for development and regulatory approval. As pharmaceutical companies and research institutions accelerate their efforts in regenerative medicine, the need for reliable cell banking partners is becoming increasingly critical.

Another crucial driver shaping the market is the increasing adoption of personalized medicine and precision therapies. With cell-based treatments becoming more patient-specific, the demand for customized cell banking solutions, including autologous and allogeneic storage services, is on the rise. Additionally, partnerships between biopharmaceutical companies and contract development and manufacturing organizations (CDMOs) are expanding, allowing for more scalable and cost-effective outsourcing solutions. As the life sciences industry continues to innovate, cell banking outsourcing is expected to play a pivotal role in advancing therapeutic breakthroughs, ensuring long-term sample viability, and supporting the next generation of biopharmaceutical development.

SCOPE OF STUDY:

The report analyzes the Cell Banking Outsourcing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking); Cell Type (Stem Cells, Non-stem Cells); Phase (Bank Storage Phase, Bank Characterization and Testing Phase, Bank Preparation Phase)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • ATCC (American Type Culture Collection)
  • BioOutsource Ltd.
  • BioReliance Corporation
  • BSL Bioservice
  • CellBank Australia
  • Charles River Laboratories, Inc.
  • Clean Biologics
  • Cordlife Group Limited
  • Covance Inc.
  • Cryo-Cell International Inc.
  • Cryoviva India
  • Eurofins Scientific
  • GBI
  • LifeCell International Pvt. Ltd
  • Lonza Group Ltd.
  • Merck KGaA
  • Paragon Bioservices, Inc.
  • Reliance Life Sciences
  • Sartorius AG
  • SGS Life Sciences

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Cell Banking Outsourcing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Biologics and Cell-Based Therapies Throws the Spotlight on Cell Banking Outsourcing Solutions
    • Rapid Growth in Cell and Gene Therapy Pipelines Propels the Need for High-Quality Master and Working Cell Banks
    • Increasing Complexity of GMP and Regulatory Compliance Strengthens the Business Case for Outsourced Cell Banking Providers
    • Expansion of Personalized Medicine and Autologous Therapies Drives Custom Cell Bank Storage Requirements
    • Biopharmaceutical Shift Toward Outsourcing Models Fuels Growth in Contract Cell Banking Services
    • Growing Adoption of cGMP-Compliant Facilities Enhances Demand for Specialized Cell Storage and Characterization Services
    • Globalization of Clinical Trials and Manufacturing Operations Expands the Addressable Market for Multi-Site Cell Banking
    • Rising Investment in Stem Cell Research and Regenerative Medicine Creates New Service Demand in Cell Banking Logistics
    • Increased Focus on Supply Chain Risk Mitigation Spurs Interest in Redundant and Disaster-Proof Cell Storage Models
    • Expansion of Allogeneic Cell Therapy Platforms Accelerates Demand for Scalable Banking Infrastructure
    • Stringent Quality Control, Authentication, and Contamination Prevention Standards Drive Laboratory Automation Adoption
    • Emergence of Biobanking-as-a-Service (BaaS) Models Creates Flexible Access for Smaller Biotech Firms
    • Integration of Digital Chain-of-Custody and Sample Tracking Technologies Enhances Service Transparency and Reliability
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Banking Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cell Banking Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Master Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Master Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Master Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Working Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Working Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Working Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Viral Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Viral Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Viral Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Non-stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Non-stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Non-stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bank Storage Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Bank Storage Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Bank Storage Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Bank Characterization & Testing Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Bank Characterization & Testing Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Bank Characterization & Testing Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Bank Preparation Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Bank Preparation Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Bank Preparation Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • JAPAN
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • CHINA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • EUROPE
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Cell Banking Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • FRANCE
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • GERMANY
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Cell Banking Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • INDIA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Cell Banking Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Cell Banking Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
  • AFRICA
    • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030

IV. COMPETITION